Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Integral membrane protein expression of human CD25 on the cell surface of HEK293 cell line: the available cellular model of CD25 positive to facilitate in vitro developing assays.

Dehbashi M, Hojati Z, Motovali-Bashi M, Ganjalikhani-Hakemi M, Shimosaka A.

Biomol Concepts. 2019 Sep 21;10(1):150-159. doi: 10.1515/bmc-2019-0018.

PMID:
31541599
2.

A Powderization Process for Encapsulating with Functional Biomaterials Using Nozzleless Electrostatic Atomization.

Mori C, Kadota K, Shimosaka A, Yoshida M, Shirakawa Y.

J Food Sci. 2019 Sep;84(9):2482-2489. doi: 10.1111/1750-3841.14783. Epub 2019 Sep 2.

PMID:
31476025
3.

DEM Modelling of Granule Rearrangement and Fracture Behaviours During a Closed-Die Compaction.

Furukawa R, Kadota K, Noguchi T, Shimosaka A, Shirakawa Y.

AAPS PharmSciTech. 2017 Aug;18(6):2368-2377. doi: 10.1208/s12249-017-0719-z. Epub 2017 Jan 26.

PMID:
28127720
4.

Kinetics of co-crystal formation with caffeine and citric acid via liquid-assisted grinding analyzed using the distinct element method.

Shimono K, Kadota K, Tozuka Y, Shimosaka A, Shirakawa Y, Hidaka J.

Eur J Pharm Sci. 2015 Aug 30;76:217-24. doi: 10.1016/j.ejps.2015.05.017. Epub 2015 May 18.

PMID:
25998562
5.

Cell therapy medical tourism: time for action.

Gunter KC, Caplan AL, Mason C, Salzman R, Janssen WE, Nichols K, Bouzas LF, Lanza F, Levine BL, Rasko JE, Shimosaka A, Horwitz E.

Cytotherapy. 2010 Dec;12(8):965-8. doi: 10.3109/14653249.2010.532663. No abstract available.

PMID:
21073261
6.

Diffusion behavior in a liquid-liquid interfacial crystallization by molecular dynamics simulations.

Kitayama A, Yamanaka S, Kadota K, Shimosaka A, Shirakawa Y, Hidaka J.

J Chem Phys. 2009 Nov 7;131(17):174707. doi: 10.1063/1.3254517.

PMID:
19895035
7.

Expansion of alpha-galactosylceramide-stimulated Valpha24+ NKT cells cultured in the absence of animal materials.

Harada Y, Imataki O, Heike Y, Kawai H, Shimosaka A, Mori S, Kami M, Tanosaki R, Ikarashi Y, Iizuka A, Yoshida M, Wakasugi H, Saito S, Takaue Y, Takei M, Kakizoe T.

J Immunother. 2005 Jul-Aug;28(4):314-21.

PMID:
16000949
8.

Freeze-thawing procedures have no influence on the phenotypic and functional development of dendritic cells generated from peripheral blood CD14+ monocytes.

Hori S, Heike Y, Takei M, Maruyama M, Inoue Y, Lee JJ, Kim HJ, Harada Y, Kawai H, Shimosaka A, Kami M, Tanosaki MD, Wakasugi H, Saito S, Takaue Y, Kakizoe T.

J Immunother. 2004 Jan-Feb;27(1):27-35.

PMID:
14676631
9.

Role of NKT cells and alpha-galactosyl ceramide.

Shimosaka A.

Int J Hematol. 2002 Aug;76 Suppl 1:277-9.

PMID:
12430864
10.

The role of PGE(2) in the differentiation of dendritic cells: how do dendritic cells influence T-cell polarization and chemokine receptor expression?

Lee JJ, Takei M, Hori S, Inoue Y, Harada Y, Tanosaki R, Kanda Y, Kami M, Makimoto A, Mineishi S, Kawai H, Shimosaka A, Heike Y, Ikarashi Y, Wakasugi H, Takaue Y, Hwang TJ, Kim HJ, Kakizoe T.

Stem Cells. 2002;20(5):448-59.

11.
12.

Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo.

Scheding S, Bergmann M, Shimosaka A, Wolff P, Driessen C, Rathke G, Jaschonek K, Brugger W, Kanz L.

Transfusion. 2002 Mar;42(3):321-7.

PMID:
11961237
13.

The synergistic effect of thrombopoietin in erythropoiesis with erythropoietin and/or IL-3 and myelopoiesis with G-CSF or IL-3 from umbilical cord blood cells of full-term neonates.

Liang DC, Shih LY, Kuo MC, Chai IJ, Su TH, Chen SH, Liu HC, Shimosaka A.

Pediatr Hematol Oncol. 2001 Sep;18(6):383-91.

PMID:
11554233
14.

Role of the microenvironment of the embryonic aorta-gonad-mesonephros region in hematopoiesis.

Nishikawa M, Tahara T, Hinohara A, Miyajima A, Nakahata T, Shimosaka A.

Ann N Y Acad Sci. 2001 Jun;938:109-16. Review.

PMID:
11458497
15.

Involvement of protein kinase C-epsilon in signal transduction of thrombopoietin in enhancement of interleukin-3-dependent proliferation of primitive hematopoietic progenitors.

Shiroshita N, Musashi M, Sakurada K, Kimura K, Tsuda Y, Ota S, Iwasaki H, Miyazaki T, Kato T, Miyazaki H, Shimosaka A, Asaka M.

J Pharmacol Exp Ther. 2001 Jun;297(3):868-75.

PMID:
11356906
16.

Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells.

Nakagawa R, Serizawa I, Motoki K, Sato M, Ueno H, Iijima R, Nakamura H, Shimosaka A, Koezuka Y.

Oncol Res. 2000;12(2):51-8.

PMID:
11132924
17.

The synergistic effect of thrombopoietin in erythropoiesis and myelopoiesis from human bone marrow cells.

Liang D, Shih LY, Kuo MC, Chen SH, Liu HC, Shimosaka A.

Acta Haematol. 2000;102(3):135-9.

PMID:
10692676
18.
19.

Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000.

Nakagawa R, Motoki K, Ueno H, Iijima R, Nakamura H, Kobayashi E, Shimosaka A, Koezuka Y.

Cancer Res. 1998 Mar 15;58(6):1202-7.

20.

Serum thrombopoietin levels in patients receiving high-dose chemotherapy with support of purified peripheral blood CD34+ cells.

Okamoto Y, Kawano Y, Takaue Y, Watanabe T, Kato T, Shimosaka A, Kuroda Y.

Cancer Res. 1997 Nov 15;57(22):5037-40.

21.

Evaluation of a cytokine combination including thrombopoietin for improved transduction of a retroviral gene into G-CSF-mobilized CD34+ human blood cells.

Kim HJ, Okamoto Y, Ito M, Takaue Y, Kawano Y, Watanabe T, Yamaue T, Tohda Y, Ogose T, Shimada T, Shimosaka A, Kuroda Y.

Stem Cells. 1997;15(5):347-52.

22.

Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists.

Oda A, Miyakawa Y, Druker BJ, Ozaki K, Yabusaki K, Shirasawa Y, Handa M, Kato T, Miyazaki H, Shimosaka A, Ikeda Y.

Blood. 1996 Jun 1;87(11):4664-70.

PMID:
8639835
23.

Establishment and characterization of a new human mesothelioma cell line (T-85) from malignant peritoneal mesothelioma with remarkable thrombocytosis.

Tange T, Hasegawa Y, Oka T, Sunaga S, Higashihara M, Matsuo K, Miyazaki H, Shimosaka A, Okano A, Todokoro K.

Pathol Int. 1995 Nov;45(11):791-800.

PMID:
8581142
24.

Thrombopoietin (TPO) induces tyrosine phosphorylation and activation of STAT5 and STAT3.

Bacon CM, Tortolani PJ, Shimosaka A, Rees RC, Longo DL, O'Shea JJ.

FEBS Lett. 1995 Aug 14;370(1-2):63-8.

25.

Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2.

Tortolani PJ, Johnston JA, Bacon CM, McVicar DW, Shimosaka A, Linnekin D, Longo DL, O'Shea JJ.

Blood. 1995 Jun 15;85(12):3444-51.

PMID:
7780132
26.

Exogenous expression of human granulocyte colony-stimulating factor receptor in a B-lineage acute lymphoblastic leukemia cell line: a possible model for mixed lineage leukemia.

el-Sonbaty SS, Tsuchiya H, Watanabe M, Hochito K, Kunisada T, Shimosaka A, Matsuda I.

Leuk Res. 1995 Apr;19(4):249-56.

PMID:
7538617
27.

Pharmacokinetics and application of erythropoietin therapy: overview of epoetin alfa studies in Japan.

Shimosaka A.

Ann N Y Acad Sci. 1994 Apr 15;718:111-22. Review. No abstract available.

PMID:
8185220
28.

Analysis of myeloid characteristics in acute lymphoblastic leukemia.

Tsuchiya H, el-Sonbaty SS, Watanabe M, Suzushima H, Asou N, Murakami T, Takeda T, Shimosaka A, Takatsuki K, Matsuda I.

Leuk Res. 1993 Sep;17(9):809-13.

PMID:
7690437
29.

Anemia induced in splenectomized mice by administration of rhG-CSF.

Cronkite EP, Burlington H, Shimosaka A, Bullis JE, Pappas N.

Exp Hematol. 1993 Feb;21(2):319-25.

PMID:
7678815
30.

Granulocyte colony-stimulating factor (G-CSF) receptors on acute myeloblastic leukaemia cells and their relationship with the proliferative response to G-CSF in clonogenic assay.

Motoji T, Watanabe M, Uzumaki H, Kusaka M, Fukamachi H, Shimosaka A, Oshimi K, Mizoguchi H.

Br J Haematol. 1991 Jan;77(1):54-9.

PMID:
1705433
31.

Recombinant human granulocyte colony-stimulating factor in allogeneic bone marrow transplantation.

Masaoka T, Takaku F, Kato S, Moriyama Y, Kodera Y, Kanamaru A, Shimosaka A, Shibata H, Nakamura H.

Exp Hematol. 1989 Nov;17(10):1047-50. No abstract available.

PMID:
2478381
32.

Is recombinant human granulocyte colony-stimulating factor (G-CSF) orally available in rats?

Takada K, Tohyama Y, Oohashi M, Yoshikawa H, Muranishi S, Shimosaka A, Kaneko T.

Chem Pharm Bull (Tokyo). 1989 Mar;37(3):838-9.

PMID:
2473849
33.

Arugomycin, a new anthracycline antibiotic. III. Biological activities of arugomycin and its analogues obtained by chemical degradation and modification.

Shimosaka A, Kawai H, Hayakawa Y, Komeshima N, Nakagawa M, Seto H, Otake N.

J Antibiot (Tokyo). 1987 Sep;40(9):1283-91.

34.

Isolation of new anthracycline antibiotics, A447 C and D.

Shimosaka A, Hayakawa Y, Nakagawa M, Furihata K, Seto H, Otake N.

J Antibiot (Tokyo). 1987 Jan;40(1):116-21. No abstract available.

Supplemental Content

Loading ...
Support Center